| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $332.1M | +51.1% |
| Cost of Revenue | $60.2M | +33.8% |
| R&D Expense | $52.0M | -2.9% |
| SG&A Expense | $200.0M | +11.0% |
| Operating Income | $8.7M | +112.8% |
| Income Tax | $3.3M | +3186.1% |
| Net Income | $18.2M | +131.7% |
| EPS (Basic) | $0.66 | +130.8% |
| EPS (Diluted) | $0.62 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $119.7M | +21.1% |
| Short-term Investments | $173.4M | +20.2% |
| Accounts Receivable | $51.2M | +33.7% |
| Inventory | $8.1M | +2.4% |
| Current Assets | $360.2M | +21.8% |
| Total Assets | $531.2M | +17.2% |
| Current Liabilities | $49.4M | +3.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $64.9M | +1253.0% |
| Capital Expenditures | $28.3M | +108.0% |
| Investing Cash Flow | -$50.1M | -209.8% |
| Financing Cash Flow | $6.1M | +367.1% |
| Free Cash Flow | $36.5M | +289.8% |
| +129.0% |
| Long-term Debt |
| $10.0M |
| — |
| Total Liabilities | $75.4M | +21.5% |
| Stockholders' Equity | $455.8M | +16.5% |